Stocktoria
HERON THERAPEUTICS, INC. /DE/ HRTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1987-08-26
HERON THERAPEUTICS, INC. /DE/ financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $154.9M | $144.3M | $127.0M | $107.7M | $86.3M |
| Gross profit | $113.6M | $105.6M | $61.9M | $52.8M | — |
| R&D expense | $12.4M | $16.7M | $39.1M | $82.7M | $130.8M |
| Operating income | -$2.5M | -$11.5M | -$110.6M | -$174.7M | -$217.8M |
| Interest expense | — | — | $3.9M | $2.5M | $2.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$20.2M | -$13.6M | -$110.6M | -$182.0M | -$220.7M |
| EPS (diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
| Operating cash flow | -$27.6M | -$22.5M | -$58.8M | -$146.9M | -$203.4M |
| Free cash flow | -$27.9M | -$24.2M | -$60.3M | -$148.7M | -$206.4M |
| Cash & equivalents | $28.6M | $25.8M | $28.7M | $15.4M | $90.5M |
| Inventory | $92.7M | $53.2M | $42.1M | $54.6M | $48.4M |
| Total assets | $255.9M | $233.1M | $222.5M | $251.0M | $305.7M |
| Total liabilities | $241.5M | $266.8M | $256.5M | $237.4M | $228.1M |
| Shareholders' equity | $14.3M | -$33.7M | -$34.0M | $13.6M | $77.6M |
Source: SEC EDGAR filings · CIK 0000818033 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.